SCHEMBL19953198

SCHEMBL19953198

Fc1ccc(-c2cnc(Cl)n2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.68
PTGS1 P23219 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ATM Q13315 1/20 0.45
PIK3CA P42336 1/20 0.44
TP53 P04637 2/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
KCNH2 Q12809 1/20 0.41
AOC3 Q16853 1/20 0.41
LMNA P02545 1/20 0.41
NPC1 O15118 1/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3824723 0.84 PTGS2 (0.51) PTGS2MEN1KMT2AATMPIK3CA
SCHEMBL1075370 0.84 PTGS2 (0.67) PTGS2PTGS1MEN1KMT2AATM
SCHEMBL6294278 0.84 PTGS2 (0.64) PTGS2PTGS1
SCHEMBL19953204 0.83 PTGS2 (0.49) PTGS2KCNH2AOC3LMNAHSD17B10
SCHEMBL6289831 0.82 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL19953110 0.73 PTGS2 (0.40) PTGS2PTGS1KCNH2AOC3
SCHEMBL19953203 0.73 PTGS2 (0.43) PTGS2PTGS1PIK3CAKCNH2AOC3
SCHEMBL19953122 0.71 HSP90AA1 (0.46) MEN1KMT2AATMTP53KCNH2
SCHEMBL6290551 0.70 PTGS2 (0.49) PTGS2PTGS1MAPK1LMNANPC1
SCHEMBL13817453 0.69 ALDH1A1 (0.73) MEN1KMT2AATMMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed